ID   FDFT_HUMAN              Reviewed;         417 AA.
AC   P37268; B3KQ95; B4DJE5; B4DT56; B7Z1J3; Q96GT0;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   07-APR-2021, entry version 213.
DE   RecName: Full=Squalene synthase;
DE            Short=SQS;
DE            Short=SS;
DE            EC=2.5.1.21 {ECO:0000269|PubMed:10896663, ECO:0000269|PubMed:24531458};
DE   AltName: Full=FPP:FPP farnesyltransferase;
DE   AltName: Full=Farnesyl-diphosphate farnesyltransferase;
DE   AltName: Full=Farnesyl-diphosphate farnesyltransferase 1 {ECO:0000312|HGNC:HGNC:3629};
GN   Name=FDFT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8474436; DOI=10.1128/mcb.13.5.2706;
RA   Robinson G.W., Tsay Y.H., Kienzle B.K., Smith-Monroy C.A., Bishop R.W.;
RT   "Conservation between human and fungal squalene synthetases: similarities
RT   in structure, function, and regulation.";
RL   Mol. Cell. Biol. 13:2706-2717(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7685352;
RA   Jiang G., McKenzie T.L., Conrad D.G., Shechter I.;
RT   "Transcriptional regulation by lovastatin and 25-hydroxycholesterol in
RT   HepG2 cells and molecular cloning and expression of the cDNA for the human
RT   hepatic squalene synthase.";
RL   J. Biol. Chem. 268:12818-12824(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8294001; DOI=10.1016/0378-1119(93)90462-c;
RA   Summers C., Karst F., Charles A.D.;
RT   "Cloning, expression and characterisation of the cDNA encoding human
RT   hepatic squalene synthase, and its relationship to phytoene synthase.";
RL   Gene 136:185-192(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7864626; DOI=10.1006/abbi.1995.1095;
RA   Soltis D.A., McMahon G., Caplan S.L., Dudas D.A., Chamberlin H.A.,
RA   Vattay A., Dottavio D., Rucker M.L., Engstrom R.G., Cornell-Kennon S.A.;
RT   "Expression, purification, and characterization of the human squalene
RT   synthase: use of yeast and baculoviral systems.";
RL   Arch. Biochem. Biophys. 316:713-723(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4 AND 5).
RC   TISSUE=Cerebellum, Pericardium, Subthalamic nucleus, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ARG-45.
RC   TISSUE=Lung, Muscle, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   INVOLVEMENT IN SQSD, AND TISSUE SPECIFICITY.
RX   PubMed=29909962; DOI=10.1016/j.ajhg.2018.05.004;
RA   Coman D., Vissers L.E.L.M., Riley L.G., Kwint M.P., Hauck R., Koster J.,
RA   Geuer S., Hopkins S., Hallinan B., Sweetman L., Engelke U.F.H.,
RA   Burrow T.A., Cardinal J., McGill J., Inwood A., Gurnsey C., Waterham H.R.,
RA   Christodoulou J., Wevers R.A., Pitt J.;
RT   "Squalene synthase deficiency: clinical, biochemical, and molecular
RT   characterization of a defect in cholesterol biosynthesis.";
RL   Am. J. Hum. Genet. 103:125-130(2018).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 39-370, CATALYTIC ACTIVITY, AND
RP   FUNCTION.
RX   PubMed=10896663; DOI=10.1074/jbc.m004132200;
RA   Pandit J., Danley D.E., Schulte G.K., Mazzalupo S., Pauly T.A.,
RA   Hayward C.M., Hamanaka E.S., Thompson J.F., Harwood H.J. Jr.;
RT   "Crystal structure of human squalene synthase. A key enzyme in cholesterol
RT   biosynthesis.";
RL   J. Biol. Chem. 275:30610-30617(2000).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 31-370 IN COMPLEX WITH MAGNESIUM
RP   ION, COFACTOR, NADP BINDING SITES, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=24531458; DOI=10.1107/s1399004713026230;
RA   Liu C.I., Jeng W.Y., Chang W.J., Shih M.F., Ko T.P., Wang A.H.;
RT   "Structural insights into the catalytic mechanism of human squalene
RT   synthase.";
RL   Acta Crystallogr. D 70:231-241(2014).
RN   [14]
RP   VARIANT ARG-45, AND ASSOCIATION WITH PLASMA CHOLESTEROL LEVELS.
RX   PubMed=18350552; DOI=10.1002/humu.20702;
RA   Do R., Pare G., Montpetit A., Hudson T.J., Gaudet D., Engert J.C.;
RT   "K45R variant of squalene synthase increases total cholesterol levels in
RT   two study samples from a French Canadian population.";
RL   Hum. Mutat. 29:689-694(2008).
CC   -!- FUNCTION: Catalyzes the condensation of 2 farnesyl pyrophosphate (FPP)
CC       moieties to form squalene. Proceeds in two distinct steps. In the first
CC       half-reaction, two molecules of FPP react to form the stable
CC       presqualene diphosphate intermediate (PSQPP), with concomitant release
CC       of a proton and a molecule of inorganic diphosphate. In the second
CC       half-reaction, PSQPP undergoes heterolysis, isomerization, and
CC       reduction with NADPH or NADH to form squalene. It is the first
CC       committed enzyme of the sterol biosynthesis pathway.
CC       {ECO:0000269|PubMed:10896663, ECO:0000269|PubMed:24531458}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (2E,6E)-farnesyl diphosphate + H(+) + NADPH = 2 diphosphate
CC         + NADP(+) + squalene; Xref=Rhea:RHEA:32295, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15440, ChEBI:CHEBI:33019, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:175763; EC=2.5.1.21;
CC         Evidence={ECO:0000269|PubMed:10896663};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32296;
CC         Evidence={ECO:0000305|PubMed:10896663};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (2E,6E)-farnesyl diphosphate + H(+) + NADH = 2 diphosphate +
CC         NAD(+) + squalene; Xref=Rhea:RHEA:32299, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15440, ChEBI:CHEBI:33019, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:175763; EC=2.5.1.21;
CC         Evidence={ECO:0000269|PubMed:10896663};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32300;
CC         Evidence={ECO:0000305|PubMed:10896663};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (2E,6E)-farnesyl diphosphate = diphosphate + presqualene
CC         diphosphate; Xref=Rhea:RHEA:22672, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57310, ChEBI:CHEBI:175763;
CC         Evidence={ECO:0000269|PubMed:10896663, ECO:0000269|PubMed:24531458};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22673;
CC         Evidence={ECO:0000305|PubMed:24531458};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADH + presqualene diphosphate = diphosphate + NAD(+) +
CC         squalene; Xref=Rhea:RHEA:22228, ChEBI:CHEBI:15378, ChEBI:CHEBI:15440,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57310, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:10896663,
CC         ECO:0000269|PubMed:24531458};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22229;
CC         Evidence={ECO:0000305|PubMed:24531458};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + presqualene diphosphate = diphosphate + NADP(+)
CC         + squalene; Xref=Rhea:RHEA:22232, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15440, ChEBI:CHEBI:33019, ChEBI:CHEBI:57310,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000269|PubMed:10896663, ECO:0000269|PubMed:24531458};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22233;
CC         Evidence={ECO:0000305|PubMed:24531458};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:24531458};
CC   -!- PATHWAY: Terpene metabolism; lanosterol biosynthesis; lanosterol from
CC       farnesyl diphosphate: step 1/3. {ECO:0000305}.
CC   -!- INTERACTION:
CC       P37268; Q13520: AQP6; NbExp=3; IntAct=EBI-714550, EBI-13059134;
CC       P37268; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-714550, EBI-11343438;
CC       P37268; P04233-2: CD74; NbExp=3; IntAct=EBI-714550, EBI-12222807;
CC       P37268; P11912: CD79A; NbExp=3; IntAct=EBI-714550, EBI-7797864;
CC       P37268; A0A024R644: CLN5; NbExp=3; IntAct=EBI-714550, EBI-12838990;
CC       P37268; O43889-2: CREB3; NbExp=3; IntAct=EBI-714550, EBI-625022;
CC       P37268; Q9GZR5: ELOVL4; NbExp=3; IntAct=EBI-714550, EBI-18535450;
CC       P37268; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-714550, EBI-18304435;
CC       P37268; P48165: GJA8; NbExp=3; IntAct=EBI-714550, EBI-17458373;
CC       P37268; Q8TDT2: GPR152; NbExp=3; IntAct=EBI-714550, EBI-13345167;
CC       P37268; Q8N5M9: JAGN1; NbExp=3; IntAct=EBI-714550, EBI-10266796;
CC       P37268; Q6IBW4-4: NCAPH2; NbExp=3; IntAct=EBI-714550, EBI-10247000;
CC       P37268; Q96RD7: PANX1; NbExp=3; IntAct=EBI-714550, EBI-7037612;
CC       P37268; Q14973: SLC10A1; NbExp=3; IntAct=EBI-714550, EBI-3923031;
CC       P37268; Q9NQQ7-3: SLC35C2; NbExp=3; IntAct=EBI-714550, EBI-17295964;
CC       P37268; Q96MV1: TLCD4; NbExp=3; IntAct=EBI-714550, EBI-12947623;
CC       P37268; Q9Y320: TMX2; NbExp=3; IntAct=EBI-714550, EBI-6447886;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q02769}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P37268-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P37268-2; Sequence=VSP_056283;
CC       Name=3;
CC         IsoId=P37268-3; Sequence=VSP_056282;
CC       Name=4;
CC         IsoId=P37268-4; Sequence=VSP_056517;
CC       Name=5;
CC         IsoId=P37268-5; Sequence=VSP_056518;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:29909962}.
CC   -!- DISEASE: Squalene synthase deficiency (SQSD) [MIM:618156]: An autosomal
CC       recessive disorder characterized by profound developmental delay, brain
CC       abnormalities, 2/3 syndactyly of the toes, facial dysmorphisms, low
CC       total and LDL-cholesterol, and abnormal urine organic acids.
CC       {ECO:0000269|PubMed:29909962}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the phytoene/squalene synthase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L06070; AAA60582.1; -; mRNA.
DR   EMBL; L06105; AAA36645.1; -; mRNA.
DR   EMBL; X69141; CAA48896.1; -; mRNA.
DR   EMBL; S76822; AAB33404.1; -; mRNA.
DR   EMBL; AK057726; BAG51957.1; -; mRNA.
DR   EMBL; AK293545; BAH11529.1; -; mRNA.
DR   EMBL; AK296043; BAG58807.1; -; mRNA.
DR   EMBL; AK300059; BAG61868.1; -; mRNA.
DR   EMBL; AK315993; BAH14364.1; -; mRNA.
DR   EMBL; AK316351; BAH14722.1; -; mRNA.
DR   EMBL; AK316531; BAH14902.1; -; mRNA.
DR   EMBL; AK316534; BAH14905.1; -; mRNA.
DR   EMBL; AC069185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003573; AAH03573.1; -; mRNA.
DR   EMBL; BC009251; AAH09251.1; -; mRNA.
DR   EMBL; BC029641; AAH29641.1; -; mRNA.
DR   CCDS; CCDS5985.1; -. [P37268-1]
DR   CCDS; CCDS75696.1; -. [P37268-2]
DR   CCDS; CCDS75697.1; -. [P37268-3]
DR   PIR; A45998; A45998.
DR   PIR; I38245; I38245.
DR   PIR; I52090; I52090.
DR   RefSeq; NP_001274671.1; NM_001287742.1. [P37268-1]
DR   RefSeq; NP_001274672.1; NM_001287743.1. [P37268-1]
DR   RefSeq; NP_001274673.1; NM_001287744.1. [P37268-2]
DR   RefSeq; NP_001274674.1; NM_001287745.1. [P37268-2]
DR   RefSeq; NP_001274676.1; NM_001287747.1. [P37268-2]
DR   RefSeq; NP_001274677.1; NM_001287748.1. [P37268-2]
DR   RefSeq; NP_001274678.1; NM_001287749.1. [P37268-2]
DR   RefSeq; NP_001274679.1; NM_001287750.1.
DR   RefSeq; NP_001274680.1; NM_001287751.1. [P37268-3]
DR   RefSeq; NP_001274685.1; NM_001287756.1.
DR   RefSeq; NP_004453.3; NM_004462.4. [P37268-1]
DR   RefSeq; XP_016868706.1; XM_017013217.1.
DR   PDB; 1EZF; X-ray; 2.15 A; A/B/C=31-370.
DR   PDB; 3ASX; X-ray; 2.00 A; A=31-370.
DR   PDB; 3LEE; X-ray; 3.20 A; A/B/C/D/E/F=31-370.
DR   PDB; 3Q2Z; X-ray; 2.00 A; A=31-370.
DR   PDB; 3Q30; X-ray; 2.00 A; A=31-370.
DR   PDB; 3V66; X-ray; 1.80 A; A=31-370.
DR   PDB; 3VJ8; X-ray; 1.52 A; A=31-370.
DR   PDB; 3VJ9; X-ray; 1.52 A; A=31-370.
DR   PDB; 3VJA; X-ray; 1.76 A; A/B=31-370.
DR   PDB; 3VJB; X-ray; 2.05 A; A/B/C/D/E/F=31-370.
DR   PDB; 3VJC; X-ray; 1.89 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WC9; X-ray; 2.82 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCD; X-ray; 2.75 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCF; X-ray; 2.22 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCH; X-ray; 2.50 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCI; X-ray; 2.30 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCJ; X-ray; 2.20 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCL; X-ray; 2.24 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCM; X-ray; 2.06 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WEF; X-ray; 2.35 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WEG; X-ray; 1.75 A; A=31-370.
DR   PDB; 3WEH; X-ray; 1.87 A; A=31-370.
DR   PDB; 3WEI; X-ray; 1.79 A; A=31-370.
DR   PDB; 3WEJ; X-ray; 2.00 A; A=31-370.
DR   PDB; 3WEK; X-ray; 1.85 A; A=31-370.
DR   PDB; 3WSA; X-ray; 2.90 A; A/B/C/D/E/F=31-370.
DR   PDB; 6PYJ; X-ray; 1.44 A; C=280-288.
DR   PDB; 6PYV; X-ray; 1.45 A; C=280-288.
DR   PDB; 6PYW; X-ray; 1.38 A; C=280-288.
DR   PDB; 6PZ5; X-ray; 1.53 A; C=280-288.
DR   PDBsum; 1EZF; -.
DR   PDBsum; 3ASX; -.
DR   PDBsum; 3LEE; -.
DR   PDBsum; 3Q2Z; -.
DR   PDBsum; 3Q30; -.
DR   PDBsum; 3V66; -.
DR   PDBsum; 3VJ8; -.
DR   PDBsum; 3VJ9; -.
DR   PDBsum; 3VJA; -.
DR   PDBsum; 3VJB; -.
DR   PDBsum; 3VJC; -.
DR   PDBsum; 3WC9; -.
DR   PDBsum; 3WCD; -.
DR   PDBsum; 3WCF; -.
DR   PDBsum; 3WCH; -.
DR   PDBsum; 3WCI; -.
DR   PDBsum; 3WCJ; -.
DR   PDBsum; 3WCL; -.
DR   PDBsum; 3WCM; -.
DR   PDBsum; 3WEF; -.
DR   PDBsum; 3WEG; -.
DR   PDBsum; 3WEH; -.
DR   PDBsum; 3WEI; -.
DR   PDBsum; 3WEJ; -.
DR   PDBsum; 3WEK; -.
DR   PDBsum; 3WSA; -.
DR   PDBsum; 6PYJ; -.
DR   PDBsum; 6PYV; -.
DR   PDBsum; 6PYW; -.
DR   PDBsum; 6PZ5; -.
DR   SMR; P37268; -.
DR   BioGRID; 108516; 82.
DR   IntAct; P37268; 43.
DR   STRING; 9606.ENSP00000480828; -.
DR   BindingDB; P37268; -.
DR   ChEMBL; CHEMBL3338; -.
DR   DrugBank; DB05317; TAK-475.
DR   DrugCentral; P37268; -.
DR   GuidetoPHARMACOLOGY; 645; -.
DR   SwissLipids; SLP:000000138; -.
DR   iPTMnet; P37268; -.
DR   MetOSite; P37268; -.
DR   PhosphoSitePlus; P37268; -.
DR   SwissPalm; P37268; -.
DR   BioMuta; FDFT1; -.
DR   DMDM; 585126; -.
DR   EPD; P37268; -.
DR   jPOST; P37268; -.
DR   MassIVE; P37268; -.
DR   PaxDb; P37268; -.
DR   PeptideAtlas; P37268; -.
DR   PRIDE; P37268; -.
DR   ProteomicsDB; 3554; -.
DR   ProteomicsDB; 4370; -.
DR   ProteomicsDB; 5075; -.
DR   ProteomicsDB; 55271; -. [P37268-1]
DR   ProteomicsDB; 6339; -.
DR   Antibodypedia; 1355; 431 antibodies.
DR   DNASU; 2222; -.
DR   Ensembl; ENST00000220584; ENSP00000220584; ENSG00000079459. [P37268-1]
DR   Ensembl; ENST00000443614; ENSP00000390367; ENSG00000079459. [P37268-5]
DR   Ensembl; ENST00000525777; ENSP00000436069; ENSG00000079459. [P37268-3]
DR   Ensembl; ENST00000528643; ENSP00000431649; ENSG00000079459. [P37268-3]
DR   Ensembl; ENST00000528812; ENSP00000431749; ENSG00000079459. [P37268-2]
DR   Ensembl; ENST00000530664; ENSP00000432331; ENSG00000079459. [P37268-2]
DR   Ensembl; ENST00000538689; ENSP00000444248; ENSG00000079459. [P37268-2]
DR   Ensembl; ENST00000615631; ENSP00000481481; ENSG00000079459. [P37268-1]
DR   Ensembl; ENST00000618539; ENSP00000480828; ENSG00000079459. [P37268-1]
DR   Ensembl; ENST00000622850; ENSP00000484122; ENSG00000079459. [P37268-2]
DR   Ensembl; ENST00000623368; ENSP00000485229; ENSG00000079459. [P37268-2]
DR   GeneID; 2222; -.
DR   KEGG; hsa:2222; -.
DR   UCSC; uc003wuh.4; human. [P37268-1]
DR   CTD; 2222; -.
DR   DisGeNET; 2222; -.
DR   GeneCards; FDFT1; -.
DR   GeneReviews; FDFT1; -.
DR   HGNC; HGNC:3629; FDFT1.
DR   HPA; ENSG00000079459; Low tissue specificity.
DR   MalaCards; FDFT1; -.
DR   MIM; 184420; gene.
DR   MIM; 618156; phenotype.
DR   neXtProt; NX_P37268; -.
DR   OpenTargets; ENSG00000079459; -.
DR   PharmGKB; PA28073; -.
DR   VEuPathDB; HostDB:ENSG00000079459.12; -.
DR   eggNOG; KOG1459; Eukaryota.
DR   GeneTree; ENSGT00390000016034; -.
DR   HOGENOM; CLU_031981_0_2_1; -.
DR   InParanoid; P37268; -.
DR   OMA; NGPNEKD; -.
DR   OrthoDB; 563702at2759; -.
DR   PhylomeDB; P37268; -.
DR   TreeFam; TF105316; -.
DR   BioCyc; MetaCyc:HS01329-MONOMER; -.
DR   BRENDA; 2.5.1.21; 2681.
DR   PathwayCommons; P37268; -.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   SABIO-RK; P37268; -.
DR   UniPathway; UPA00767; UER00751.
DR   BioGRID-ORCS; 2222; 59 hits in 995 CRISPR screens.
DR   ChiTaRS; FDFT1; human.
DR   EvolutionaryTrace; P37268; -.
DR   GenomeRNAi; 2222; -.
DR   Pharos; P37268; Tchem.
DR   PRO; PR:P37268; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P37268; protein.
DR   Bgee; ENSG00000079459; Expressed in testis and 249 other tissues.
DR   ExpressionAtlas; P37268; baseline and differential.
DR   Genevisible; P37268; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0004310; F:farnesyl-diphosphate farnesyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051996; F:squalene synthase activity; IBA:GO_Central.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IBA:GO_Central.
DR   GO; GO:0045338; P:farnesyl diphosphate metabolic process; IBA:GO_Central.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; TAS:Reactome.
DR   GO; GO:0019222; P:regulation of metabolic process; TAS:Reactome.
DR   GO; GO:0006694; P:steroid biosynthetic process; TAS:ProtInc.
DR   CDD; cd00683; Trans_IPPS_HH; 1.
DR   Gene3D; 1.10.600.10; -; 1.
DR   InterPro; IPR008949; Isoprenoid_synthase_dom_sf.
DR   InterPro; IPR002060; Squ/phyt_synthse.
DR   InterPro; IPR006449; Squal_synth-like.
DR   InterPro; IPR019845; Squalene/phytoene_synthase_CS.
DR   InterPro; IPR033904; Trans_IPPS_HH.
DR   SFLD; SFLDG01018; Squalene/Phytoene_Synthase_Lik; 1.
DR   SUPFAM; SSF48576; SSF48576; 1.
DR   TIGRFAMs; TIGR01559; squal_synth; 1.
DR   PROSITE; PS01044; SQUALEN_PHYTOEN_SYN_1; 1.
DR   PROSITE; PS01045; SQUALEN_PHYTOEN_SYN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol biosynthesis;
KW   Cholesterol metabolism; Endoplasmic reticulum; Lipid biosynthesis;
KW   Lipid metabolism; Magnesium; Membrane; Metal-binding;
KW   Multifunctional enzyme; NAD; NADP; Reference proteome;
KW   Steroid biosynthesis; Steroid metabolism; Sterol biosynthesis;
KW   Sterol metabolism; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..417
FT                   /note="Squalene synthase"
FT                   /id="PRO_0000067443"
FT   TRANSMEM        284..304
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        384..404
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   METAL           80
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000269|PubMed:24531458,
FT                   ECO:0007744|PDB:3WEG, ECO:0007744|PDB:3WEH"
FT   METAL           83
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000269|PubMed:24531458,
FT                   ECO:0007744|PDB:3WEG, ECO:0007744|PDB:3WEH"
FT   METAL           84
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000269|PubMed:24531458,
FT                   ECO:0007744|PDB:3WEG, ECO:0007744|PDB:3WEH"
FT   BINDING         52
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:24531458"
FT   BINDING         77
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:24531458"
FT   BINDING         218
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:24531458"
FT   BINDING         315
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:24531458"
FT   BINDING         317
FT                   /note="NADP"
FT                   /evidence="ECO:0000305|PubMed:24531458"
FT   VAR_SEQ         1..111
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056517"
FT   VAR_SEQ         1..85
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056282"
FT   VAR_SEQ         1..64
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056283"
FT   VAR_SEQ         128..170
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056518"
FT   VARIANT         45
FT                   /note="K -> R (influences plasma cholesterol levels;
FT                   associated with increased total cholesterol and non-high-
FT                   density lipoprotein cholesterol; dbSNP:rs4731)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:18350552"
FT                   /id="VAR_011786"
FT   VARIANT         392
FT                   /note="L -> P (in dbSNP:rs1804473)"
FT                   /id="VAR_011787"
FT   CONFLICT        353
FT                   /note="D -> N (in Ref. 4; AAB33404)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        402
FT                   /note="T -> A (in Ref. 3; CAA48896)"
FT                   /evidence="ECO:0000305"
FT   HELIX           38..51
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           52..54
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           55..59
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           65..84
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           90..103
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   TURN            117..119
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           120..123
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           125..134
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           137..156
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           157..159
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           165..175
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           177..189
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   STRAND          191..193
FT                   /evidence="ECO:0007744|PDB:3WEK"
FT   HELIX           195..199
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           201..218
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           220..225
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           233..236
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   TURN            237..239
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           243..247
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           249..251
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           252..267
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           270..278
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           283..303
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           307..310
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           318..327
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   STRAND          328..330
FT                   /evidence="ECO:0007744|PDB:3VJC"
FT   HELIX           331..346
FT                   /evidence="ECO:0007744|PDB:3VJ8"
FT   HELIX           356..368
FT                   /evidence="ECO:0007744|PDB:3VJ8"
SQ   SEQUENCE   417 AA;  48115 MW;  D36CBC8382F827EC CRC64;
     MEFVKCLGHP EEFYNLVRFR IGGKRKVMPK MDQDSLSSSL KTCYKYLNQT SRSFAAVIQA
     LDGEMRNAVC IFYLVLRALD TLEDDMTISV EKKVPLLHNF HSFLYQPDWR FMESKEKDRQ
     VLEDFPTISL EFRNLAEKYQ TVIADICRRM GIGMAEFLDK HVTSEQEWDK YCHYVAGLVG
     IGLSRLFSAS EFEDPLVGED TERANSMGLF LQKTNIIRDY LEDQQGGREF WPQEVWSRYV
     KKLGDFAKPE NIDLAVQCLN ELITNALHHI PDVITYLSRL RNQSVFNFCA IPQVMAIATL
     AACYNNQQVF KGAVKIRKGQ AVTLMMDATN MPAVKAIIYQ YMEEIYHRIP DSDPSSSKTR
     QIISTIRTQN LPNCQLISRS HYSPIYLSFV MLLAALSWQY LTTLSQVTED YVQTGEH
//
